Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review (Q38414352)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 April 2015

Language	Label	Description	Also known as
English	Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review	scientific article published on 10 April 2015

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review (English)

1 reference

Europe PubMed Central

2 September 2017

anti-retroviral agent

0 references

immune reconstitution inflammatory syndrome

1 reference

based on heuristic

inferred from title

opportunistic infection

1 reference

based on heuristic

inferred from title

3

object named as

Emilio Letang

1 reference

Europe PubMed Central

2 September 2017

author name string

Christian Manzardo

1

1 reference

Europe PubMed Central

2 September 2017

Alberto C Guardo

2

1 reference

Europe PubMed Central

2 September 2017

Montserrat Plana

4

1 reference

Europe PubMed Central

2 September 2017

Jose M Gatell

5

1 reference

Europe PubMed Central

2 September 2017

Jose M Miro

6

1 reference

Europe PubMed Central

2 September 2017

publication date

10 April 2015

1 reference

Europe PubMed Central

2 September 2017

Expert Review of Anti-infective Therapy

1 reference

Europe PubMed Central

2 September 2017

13

1 reference

Europe PubMed Central

2 September 2017

6

1 reference

Europe PubMed Central

2 September 2017

751-767

1 reference

Europe PubMed Central

2 September 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Patients presenting with AIDS in the HAART era: a collaborative cohort analysis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Delayed Presentation and Late Testing for HIV: Demographic and Behavioral Risk Factors in a Multicenter Study in Italy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Optimal timing and best antiretroviral regimen in treatment-naive HIV-infected individuals with advanced disease

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune restoration disease after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution inflammatory syndrome: incidence and implications for mortality

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Impact of the immune reconstitution inflammatory syndrome (IRIS) on mortality and morbidity in HIV-infected patients in Mexico

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

When to start antiretroviral therapy in HIV-associated tuberculosis.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Integration of antiretroviral therapy with tuberculosis treatment

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Clinical markers of immunodeficiency and mechanism of immune reconstitution inflammatory syndrome and highly active antiretroviral therapy on HIV: workshop 3A.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Ad

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Th17 cells: a new fate for differentiating helper T cells

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Polychromatic immunophenotypic characterization of T cell profiles among HIV-infected patients experiencing immune reconstitution inflammatory syndrome (IRIS).

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

The Effect of Highly Active Antiretroviral Therapy-Induced Immune Reconstitution on Development and Outcome of Progressive Multifocal Leukoencephalopathy: Study of 43 Cases with Review of the Literature

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Pathogenesis of the immune reconstitution inflammatory syndrome in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Matrix metalloproteinases and tissue damage in HIV-tuberculosis immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

MHC haplotypes affect the expression of opportunistic infections in HIV patients

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Multi-analyte profiling of ten cytokines in South African HIV-infected patients with Immune Reconstitution Inflammatory Syndrome (IRIS).

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution disease of the central nervous system.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Toxoplasmic encephalitis IRIS in HIV-infected patients: a case series and review of the literature

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Parvovirus B19 encephalitis presenting as immune restoration disease after highly active antiretroviral therapy for human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Extensive retinal neovascularization as a late finding in human immunodeficiency virus-infected patients with immune recovery uveitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Lower incidence and severity of cytomegalovirus-associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Microsporidial keratoconjunctivitis after HAART.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution syndrome due to bacillus Calmette-Guérin after initiation of antiretroviral therapy in children with HIV infection

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Human papillomavirus in the era of highly active antiretroviral therapy for human immunodeficiency virus: an immune reconstitution-associated disease?

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Leprosy reversal reaction as immune reconstitution inflammatory syndrome in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Bacillary splenitis (Bartonella henselae) during immune restoration in an HIV-infected patient

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Graves' disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: evidence of thymic dysfunction.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Human immunodeficiency virus-associated polymyositis during immune restoration with combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Validation of a published case definition for tuberculosis-associated immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution inflammatory syndrome associated with Mycobacterium tuberculosis infection: a systematic review

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution inflammatory syndrome (IRIS) associated with Cryptococcus neoformans infection in AIDS patients

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Pulmonary cryptococcosis misdiagnosed as smear-negative pulmonary tuberculosis with fatal consequences

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution inflammatory syndrome in natalizumab-associated PML.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Progressive multifocal leukoencephalopathy in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Progressive multifocal leucoencephalopathy with magnetic resonance imaging verification and therapeutic trials with interferon.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidone

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Sustained recovery of progressive multifocal leukoencephalopathy after treatment with IL-2.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS Cohort

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Poor prognosis of HIV-associated tuberculous meningitis regardless of the timing of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Antiretroviral therapy after cryptococcal meningitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution disorders in patients with HIV infection: from pathogenesis to prevention and treatment.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Management of tuberculosis in children and new treatment options

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Life-threatening exacerbation of Kaposi's sarcoma after prednisone treatment for immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Downregulation of leukocyte migration after treatment with CCR5 antagonist maraviroc

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Management of patients with the immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Mediators of Innate and Adaptive Immune Responses Differentially Affect Immune Restoration Disease Associated withMycobacterium tuberculosisin HIV Patients Beginning Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Tuberculosis After Commencing Antiretroviral Therapy for HIV Infection Is Associated With Elevated CXCL9 and CXCL10 Responses to Mycobacterium tuberculosis Antigens

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Combination Antifungal Therapy for Cryptococcal Meningitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029917

21 January 2018

Identifiers

10.1586/14787210.2015.1029917

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38414352&oldid=1758178820"